| 000 | 01263 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513232157.0 | ||
| 264 | 0 | _c20010503 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.21.2.169.34113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrophy, D F | |
| 245 | 0 | 0 |
_aThe pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cFeb 2001 |
||
| 300 |
_a169-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticoagulants _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aEnoxaparin _xblood |
| 650 | 0 | 4 |
_aFactor Xa _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aWazny, L D | |
| 700 | 1 | _aGehr, T W | |
| 700 | 1 | _aComstock, T J | |
| 700 | 1 | _aVenitz, J | |
| 773 | 0 |
_tPharmacotherapy _gvol. 21 _gno. 2 _gp. 169-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.21.2.169.34113 _zAvailable from publisher's website |
| 999 |
_c11151744 _d11151744 |
||